Provider QP2-21 Update for New to Market Medical Drugs: Aducanumab, Casimersen, Evinacumab, Idecabtagene Vicleucel, and Pegunigalsidase Alfa Read More
Provider P32-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Musculoskeletal Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers Read More
Provider P22-21 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements Read More
Provider P27-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective July 5, 2021 Read More
Provider P20-21 Removal of Four Medicare Platinum Blue Prior Authorization Requirements — Effective June 1, 2021 Read More
